Literature DB >> 12213806

p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells.

Ning Gao1, Bing-Hua Jiang, Stephen S Leonard, Linda Corum, Zhuo Zhang, Jenny R Roberts, Jim Antonini, Jenny Z Zheng, Daniel C Flynn, Vince Castranova, Xianglin Shi.   

Abstract

Chromium(VI) (Cr(VI)) is widely used in industry and is a potent inducer of tumors in animals. The present study demonstrates that Cr(VI) induces hypoxia-inducible factor 1 (HIF-1) activity through the specific expression of HIF-1alpha but not HIF-1beta subunit and increases the level of vascular endothelial growth factor (VEGF) expression in DU145 human prostate carcinoma cells. To dissect the signaling pathways involved in Cr(VI)-induced HIF-1 expression, we found that p38 mitogen-activated protein kinase signaling was required for HIF-1alpha expression induced by Cr(VI). Neither phosphatidylinositol 3-kinase nor extracellular signal-regulated kinase activity was required for Cr(VI)-induced HIF-1 expression. Cr(VI) induced expression of HIF-1 and VEGF through the production of reactive oxygen species in DU145 cells. The major species of reactive oxygen species responsible for the induction of HIF-1 and VEGF expression is H(2)O(2). These results suggest that the expression of HIF-1 and VEGF induced by Cr(VI) may be an important signaling pathway in the Cr(VI)-induced carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213806     DOI: 10.1074/jbc.M202775200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Chromium genotoxicity: A double-edged sword.

Authors:  Kristen P Nickens; Steven R Patierno; Susan Ceryak
Journal:  Chem Biol Interact       Date:  2010-04-27       Impact factor: 5.192

Review 2.  Molecular and epigenetic mechanisms of Cr(VI)-induced carcinogenesis.

Authors:  Qiao Yi Chen; Anthony Murphy; Hong Sun; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-20       Impact factor: 4.219

3.  Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.

Authors:  Qiruo Gao; Junhua Zheng
Journal:  Cell Prolif       Date:  2018-02-19       Impact factor: 6.831

4.  Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling.

Authors:  Brooke M Emerling; Leonidas C Platanias; Emma Black; Angel R Nebreda; Roger J Davis; Navdeep S Chandel
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

Review 5.  Molecular mechanisms of Cr(VI)-induced carcinogenesis.

Authors:  Min Ding; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

6.  Cr(VI)-stimulated STAT3 tyrosine phosphorylation and nuclear translocation in human airway epithelial cells requires Lck.

Authors:  Kimberley A O'Hara; Rasilaben J Vaghjiani; Antonia A Nemec; Linda R Klei; Aaron Barchowsky
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

Review 7.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

8.  Molecular mechanisms underlying synergistic adhesion of sickle red blood cells by hypoxia and low nitric oxide bioavailability.

Authors:  Diana R Gutsaeva; Pedro Montero-Huerta; James B Parkerson; Shobha D Yerigenahally; Tohru Ikuta; C Alvin Head
Journal:  Blood       Date:  2014-01-15       Impact factor: 22.113

9.  Signal transducer and activator of transcription 1 (STAT1) is essential for chromium silencing of gene induction in human airway epithelial cells.

Authors:  Antonia A Nemec; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2009-04-29       Impact factor: 4.849

10.  Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase.

Authors:  Melyssa R Bratton; Daniel E Frigo; Katinka A Vigh-Conrad; Daju Fan; Scott Wadsworth; John A McLachlan; Matthew E Burow
Journal:  Carcinogenesis       Date:  2008-09-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.